Mr. Yu Hai joined the Group in February 2023 as an executive Director and the Chief Executive Officer, and was appointed as the Chairman of the board and the chairman of the Nomination Committee in June 2025. He is currently the chairman of China Resources Healthcare Group Limited which is an indirect controlling shareholder of the Company. Mr. YU served as the vice-chairman, the general manager and the senior vice general manager of CR Healthcare from January 2020 to June 2025 and as the chairman of Liaoning Healthcare Industry Group Co., Ltd. from July 2018 to January 2020. Mr. YU worked in Benxi Municipal Government, Liaoning Province from July 2008 to July 2018, and served as the deputy mayor of Benxi City etc. Prior to that, Mr. YU held various positions at government departments including the deputy director of the Social Development Division of the Department of Science & Technology of Liaoning Province, the deputy director of the High-tech Development and Industrialization Division of the Department of Science & Technology of Liaoning Province, the deputy director of the Bureau of Science and Technology of Nagchu District, the Tibet Autonomous Region, and the principal officer of the Industrial and Social Development Division, the Scientific and Technological Commission of Liaoning Province etc.. Mr. YU holds a doctor of science degree in pharmaceutical affairs management from the School of Pharmacy, Shenyang Pharmaceutical University.

Mr. Shan Baojie joined the Group in August 2021 as a non-executive Director and was re-designated as an executive Director in December 2021, and he is also the vice president of the Company. Mr. SHAN obtained a master degree in Accounting from Renmin University in June 2002 and a bachelor degree in Chemistry from Wuhan University in July 1992. Mr. SHAN is also currently the vice general manager of CR Healthcare, the Company’s controlling shareholder, and is also taking the office as a director of a number of its subsidiaries. Prior to joining CR Healthcare, Mr. SHAN was with the Group from 2011 to 2016 as the executive general manager and then the vice general manager, and he was also an executive Director of the Company from February 2016 to November 2016. He had served in a variety of roles at the State Food and Drug Administration from 1998 to 2011, and also completed a training program at the World Health Organization in 2007, where he gained experience in the U.S. pharmaceutical supervision and management system. From July 1992 to July 1998, Mr. SHAN worked in the general manager’s office of the Northeast Pharmaceutical Group Co., Ltd 

Mr. Wu was appointed as the Vice President of CR Medial.He is also the Vice General Manager of CR Healthcare.. He once served as chairman of China Resources Wisco Medical Management Co. , Ltd., and director of Technology Management of the WISCO., and Secretary of the Party Committee and General Manager of modern city service group of WISCO. He also served as deputy secretary-general of China Iron and Steel Industry Association and Independent Director of jinrui New Materials Technology Co. , Ltd. (listed on Shanghai Stock Exchange, stock code: 600390). With a Phd in Wuhan University of Technology, he got the title of senior engineer at Professor Level.

Ms. Yang Min was appointed as an executive Director and the Chief Financial Officer in June 2023. She is currently the chief financial officer of CR Healthcare. Previously, Ms. YANG served as the general manager of the finance department of China Resources Gas Group Limited, a company listed on the Stock Exchange (Stock Code: 1193) from December 2019 to May 2023, and she has successively served in various positions of the aforesaid company from November 2009 to December 2019 including senior deputy general manager of the finance department, deputy general manager of the audit department (acting head of department), deputy general manager of the finance department, assistant general manager of the finance department, senior manager of the finance department, assistant to the general manager and financial manager of its subsidiaries, and the expatriate responsible person of finance. Prior to that, Ms. YANG served successively as manager, senior auditor and auditor of Ernst & Young Huaming LLP Shenzhen Branch from September 2002 to November 2009. Ms. YANG holds a bachelor’s degree in management majoring in accounting from the School of Economics and Management of Northwestern University and is a Certified Public Accountant of the PRC. 

Mr.Zhang Bing was appointed as the vice president of the Company on December 23, 2024. He is also currently the vice general manager of CR Healthcare. Mr. ZHANG was successively a surgeon of Sunjiawan Hospital* （孫家灣醫院）, a physician, attending physician, vice president and president of Fuxin Mining Group Pingan Hospital* （阜新礦業集團平安醫院）, the president of 157 Hospital of Liaoning Health Group* （遼健集團一五七醫院）, and the vice president and president of Fuxin Mining General Hospital* （阜新礦總醫院）. Mr. ZHANG holds a master degree in Clinical Medicine with major in Surgery from Liaoning Medical College* （遼寧醫學院）, and holds the title of Chief Physician. 

Mr. Lu Qingrong was appointed as the vice president of the Company on December 23, 2024. He is also currently the vice general manager of CR Healthcare. Before joining the Group, Mr. LU successively worked for BYD Company Limited and ZTE Corporation. He joined Shenzhen China Resources Sanjiu Medical & Pharmaceutical Company Limited* （深圳華潤三九醫藥股份有限公司, which was listed on Shenzhen Stock Exchange, stock code: 000999) in July 2002, and successively served as a budget analyst, budget director and the director of financial management department, the general manager of strategic operation department and the general manager of big health business department. Since August 2020, he has been the general manager of strategic operation department (formerly the strategic management department) of CR Healthcare. Mr. LU holds a bachelor’s degree in Economics with major in Accounting from Fudan University, and holds the title of Intermediate Accountant.